Literature DB >> 7688314

Ras-transformed cells express both CD44 and RHAMM hyaluronan receptors: only RHAMM is essential for hyaluronan-promoted locomotion.

E A Turley1, L Austen, D Moore, K Hoare.   

Abstract

Hyaluronan (HA) is an important regulator of cell locomotion. We show that ras-transformed cells, termed 245 cells, respond to HA with an increase in random locomotion. We show that two HA receptors, RHAMM (receptor for hyaluronan-mediated motility) and CD44, are present on these ras-transformed fibroblasts. RHAMM is expressed as a 58-kDa protein and is distributed primarily as patches over lamellae. CD44 occurs largely as an 85- to 90-kDa protein that is distributed more or less evenly over the cell surface with small amounts concentrated at the tips of lamellae. CD44 and RHAMM both bind biotinylated HA in a transblot assay, indicating that they are both potential fibroblast HA receptors. CD44 binds approximately five times more HA than RHAMM as determined by densitometric analysis of transblots, indicating that this protein is the major HA receptor on fibroblasts. We assessed the role of these receptors in mediating the stimulatory effects of HA on cell motility by using antibody neutralization. Several antibodies to CD44 were used that inhibit HA/CD44 interactions. None of these had an effect on locomotory responses to HA, indicating that CD44 is not directly involved in mediating locomotion in response to HA on ras-transformed cells. In contrast, antibodies specific to RHAMM completely inhibited locomotion, indicating that RHAMM is the primary mediator of HA-promoted locomotion of ras-transformed cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7688314     DOI: 10.1006/excr.1993.1194

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  23 in total

Review 1.  Applications and emerging trends of hyaluronic acid in tissue engineering, as a dermal filler and in osteoarthritis treatment.

Authors:  A Fakhari; C Berkland
Journal:  Acta Biomater       Date:  2013-03-15       Impact factor: 8.947

2.  Hyaluronate receptors mediating glioma cell migration and proliferation.

Authors:  Y Akiyama; S Jung; B Salhia; S Lee; S Hubbard; M Taylor; T Mainprize; K Akaishi; W van Furth; J T Rutka
Journal:  J Neurooncol       Date:  2001-06       Impact factor: 4.130

3.  Characterization of invading glioma cells using molecular analysis of leading-edge tissue.

Authors:  Cheol-Soo Kim; Shin Jung; Tae-Young Jung; Woo-Youl Jang; Heung-Suk Sun; Hyang-Hwa Ryu
Journal:  J Korean Neurosurg Soc       Date:  2011-09-30

4.  Oncogene-dependent expression of CD44 in Balb/c 3T3 derivatives: correlation with metastatic competence.

Authors:  P Kogerman; M S Sy; L A Culp
Journal:  Clin Exp Metastasis       Date:  1996-01       Impact factor: 5.150

Review 5.  Role of receptor for hyaluronan-mediated motility (RHAMM) in human head and neck cancers.

Authors:  Hideo Shigeishi; Koichiro Higashikawa; Masaaki Takechi
Journal:  J Cancer Res Clin Oncol       Date:  2014-03-28       Impact factor: 4.553

6.  Intronic splicing of hyaluronan synthase 1 (HAS1): a biologically relevant indicator of poor outcome in multiple myeloma.

Authors:  Sophia Adamia; Tony Reiman; Mary Crainie; Michael J Mant; Andrew R Belch; Linda M Pilarski
Journal:  Blood       Date:  2005-02-24       Impact factor: 22.113

7.  Expression of variant CD44 epitopes in human astrocytic brain tumors.

Authors:  R H Eibl; T Pietsch; J Moll; P Skroch-Angel; K H Heider; K von Ammon; O D Wiestler; H Ponta; P Kleihues; P Herrlich
Journal:  J Neurooncol       Date:  1995-12       Impact factor: 4.130

8.  Hyaluronan Disrupts Cardiomyocyte Organization within 3D Fibrin-Based Hydrogels.

Authors:  Nesrine Bouhrira; Peter A Galie; Paul A Janmey
Journal:  Biophys J       Date:  2019-02-26       Impact factor: 4.033

Review 9.  Hyaluronan and hyaluronidase in genitourinary tumors.

Authors:  Melanie A Simpson; Vinata B Lokeshwar
Journal:  Front Biosci       Date:  2008-05-01

10.  Esterified hyaluronic acid and autologous bone in the surgical correction of the infra-bone defects.

Authors:  Andrea Ballini; Stefania Cantore; Saverio Capodiferro; Felice Roberto Grassi
Journal:  Int J Med Sci       Date:  2009-02-26       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.